Thank you for subscribing!

Plant-based, Science-backed Sustainable Wellness

How Better For You Wellness is Set to Make Waves

  • Getting Under Your Skin“As Better For You Wellness continues to build its portfolio of leading wellness brands, the Mango Moi acquisition will further bolster our skincare vertical. The global skincare market is projected to grow from $100.13B in 2021 to $145.82B by 2028. The Company’s pending acquisitions of multiple natural beauty brands synergistically combine to create a diverse offering of natural products for wellness consumers at all price points.” said BTFW CEO Ian James.
  • Recent UplistingUplistBetter For Your Wellness is pleased to announce their recent uplisting from the OTC Pink Market to the OTCQB Venture Market. With uplisting comes new opportunities for revenue through increased investor visibility among other benefits.
  • Consumers are Focused on HealthConsumers’ interest in wellness continues to grow, with 48.2% of U.S. consumers reporting an increased focus on wellness compared to 2-3 years ago.

 

There is a massive opportunity with ever-increasing consumer interest in wellness products and services and a collection of highly-experienced leaders..

Better For You Wellness, Inc. (OTCQB: BFYW) is a Columbus, Ohio-based company that is exploring and evaluating various business opportunities in the food, beverage, and consumer packaged goods (“CPG”) categories, including, but not limited to, mergers, acquisitions, or business combination transactions. It has a specific focus on the wellness niche, looking for ways to improve consumer health and happiness as a core tenet of its mission.

Let’s see how the growing wellness markets represent an excellent use of capital by the right company, making BFYW a no-brainer for the wellness-oriented investor.

 

Betting on Wellness

A recent report from McKinsey and Company shows that the global wellness market is estimated to be worth $1.5T and boasts annual growth of 5-10 percent per year.1 That’s plenty of room for an up-and-coming wellness company to move in and grab some market share. Moreover, consumers’ interest in wellness continues to grow, with 48.2% of U.S. consumers reporting an increased focus on wellness compared to 2-3 years ago. When we look at the breakdown of spending in the sector, we see 70% of consumer spending on products (think cosmetics, supplements, etc.) and 30% on services (mental health and mindfulness being the lion’s share).2 1

An essential part of the report is that consumers break wellness into six specific categories: health, fitness, nutrition, appearance, sleep, and mindfulness. Each category represents unique opportunities and challenges, which BFYW will have to keep in mind as it searches for appropriate acquisitions

So we can rationalize that consumer spending will continue to increase in the wellness market, creating more opportunities for new products and services as time goes on. The only question for BFYW is, “Where to start?”.

 

Hit the Ground Running

BFYW announced the first three acquisitions in its pipeline in 2021 and hit the ground running.

Ironwood Clay Co Inc.

Ironwood is a specialized OEM skincare manufacturer and supplier offering private label product development, turn-key production, raw materials, and bulk formulas to high-impact personal care companies across the globe and is the leading international supplier of glacial oceanic clay. Additionally, Ironwood Clay Co Inc. also owns and manufactures the NENA Skincare brand, sold in over 500 retailers throughout Canada. Better for You Wellness agreed to purchase the company for a total purchase price of approximately $25.4 million CAD in a deal expected to close in June 2022.

“Better appearance, better nutrition, and better health are three major wellness categories for consumers, and by making this profitable, vertically-integrated acquisition within the natural beauty and skincare space, Better For You Wellness can begin carving-out market share in all three wellness categories,” said Ian James, CEO of Better For You Wellness, Inc. in a recent press release. “After all, skin is our largest organ, and what we put on our bodies is just as important as what we put in them.”

Ironwood has developed over 500 formulations and already has ties with Nu Skin Enterprises, Inc. (NYSE: NUS), Walgreens Boots Alliance Inc. (NASDAQ: WBA), and more, distributing its products, ingredients, and raw materials globally to the United States, China, North Korea, and more.

With 70% of consumer dollars going to the product side, it’s probably safe to assume that starting with wellness products in the three categories that Ironwood covers will be an effective strategy.

“This established and profitable acquisition within the natural beauty and skincare space will allow Better For You Wellness to become a vertically-integrated wellness company,” Ian James adds. “As I have stated before, skin is our largest organ, and what we put on our bodies is just as important as what we put in them – making skincare a major cornerstone in an overall approach to wellness.”

Better For You Wellness, Inc. also announced its plans to acquire Mary Louise Cosmetics, an established skincare brand offering wholesome, natural, and organic beauty products to bolster its skin care vertical.

Mary Louise Cosmetics’ products are currently available direct-to-consumer and online and in retail through Macy’s Inc. (NYSE: M), JCPenney, Thirteen Lune, and more. Just days later, BFYW announced another LOI to acquire Cannuka, a pioneer and leader in the CBD-infused skincare space. Boasting some of the most efficacious ingredients on earth, like hemp-derived cannabidiol and manuka honey, Cannuka products reflect consumers’ changing demands and interests.

Cannuka products are currently available direct-to-consumer online and in retail through Ulta Beauty Inc. (NASDAQ: ULTA), Macy’s, Neiman Marcus, Express Inc. (NYSE: EXPR), QVC, HSN, Revolve Group Inc. (NYSE: RVLV), and more.

 

Not stopping there

Better For You Wellness built on its acquisition efforts by entering an agreement with all natural, vegan body, hair, and skincare brand Mango Moi.

Founded by Haitian-American and proud Chicago native Amanda Cayemitte, Mango Moi products are produced using the highest quality ingredients including mango butter, baobab oil, kukui nut oil, and murumuru butter. Its products are sold direct-to-consumer via the company’s website and have been featured on Beauty Independent, BucketListers, Do312, NBC Chicago, Yahoo! and more.

“As Better For You Wellness continues to build its portfolio of leading wellness brands, the Mango Moi acquisition will further bolster our skincare vertical, The global skincare market is projected to grow from $100.13B in 2021 to $145.82B by 2028. The Company’s pending acquisitions of multiple natural beauty brands synergistically combine to create a diverse offering of natural products for wellness consumers at all price points.”  said BTFW CEO Ian James.

 

The Wellness Sector is Here to Stay

Let’s talk about the $1.5 trillion (and growing) wellness sector for just a second.

Unsurprisingly, the coronavirus pandemic has accelerated consumer awareness and adoption around the concept of wellness, and in terms of overall spending, McKinsey estimates that consumers expect to increase their purchases of both wellness products and services over the next year. ‘The only constant is change,’ so while consumer trends may develop overtime, the vertically integrated nature of BFYW’s M&A strategy will allow the company to adapt quickly, and capitalize upon these new developments and trends with minimal disruptions or delays from the supply chain issues that many companies have been forced to deal with.

Bottom line; wellness isn’t going anywhere, and BFYW can be an excellent way to get exposure to the industry. 

Being a publicly-traded wellness company focused upon better for you wellness and science-backed sustainable services has advantages. Investor faith is at an all-time high; the available capital is plentiful, and (depending on the market) investing in a company like BFYW makes all the sense (and hopefully dollars) in the world.

 

Uplisting Brings New Opportunity

Better For Your Wellness is pleased to announce their recent uplisting from the OTC Pink Market to the OTCQB Venture Market. With uplisting comes new opportunities for revenue through increased investor visibility among other benefits.

“BFYW’s advancement to OTCQB continues the incredible growth and achievement for our company over the last few months, during which time we transformed from a blank-check company to an operating company on our wellness journey. Uplisting to the OTCQB will increase BFYW’s visibility to the investment community, particularly institutional investors, as the Company continually grows and establishes itself as a leader in the wellness industry. This broader awareness and added liquidity should expand our shareholder base while increasing value for existing shareholders,” said Ian James, Chief Executive Officer of Better For You Wellness

 

Recent Press Releases 

 

Meet the Board

Ian James

Attended Ohio University from 1984 to 1989 where he obtained a Bachelor of Arts. Mr. James was appointed as President at Green Light Acquisitions, a Cannabis and Hemp investment holding company, where his responsibilities consisted of providing the Company’s strategic vision and development leadership in mergers and acquisitions. He has held this position from June 2014 to the present. In August of 2019, Ian organized the CBD Idea Factory, which became The Ideation Lab in January 2020. Ian has served as the CBD Idea Factory and The Ideation Lab’s Chief Executive Officer from the two companies’ inception until today. From 1995 to 1996, Ian served as Merv Griffin’s Corporate Community and Governmental Relations executive, working in the highly regulated gaming industry. In February 2016, Politico magazine named Ian one of the United States’ most influential political thought leaders. Ian has served as a Board Member of the Ohio Center for Journalism since August 2020.

 

Stephen Letourneau

Attended University of Cincinnati from 1994 to 1997. Mr. Letourneau was appointed as Chief Brand Officer at Green Light Acquisitions, a Cannabis and Hemp investment holding company, where his responsibilities consisted of developing the brand ethos for consumer-packaged goods. He has held this position from June 2014 to the present. In August of 2019, Stephen organized the CBD Idea Factory, which became The Ideation Lab in January 2020. Stephen has served as the CBD Idea Factory and The Ideation Lab’s Chief Brand Officer from the two companies’ inception until today. Stephen has served as an Advisory Board Member for Nemacolin Resort in Farmington, PA since August 2015 to the present. Stephen is a Council member for the George Washington University School of Business, Digital Marketing Advisory Council member..

 

Montel Williams

Earned his media celebrity status as an Emmy Award winning television personality and radio talk show host. Mr. Williams is also a decorated Naval officer, inspirational speaker, author, wellness entrepreneur and health advocate. Additionally, Mr. Williams was a Founder of Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotechnology company that focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Mr. Williams was also the Founder of the Montel Williams MS Foundation, a 501(c)(3) organization devoted to researching Multiple Sclerosis and helping people suffering from Multiple Sclerosis. Mr. Williams enlisted in the United States Marine Corps in 1974. Mr. Williams received a B.S. in Engineering from the United States Naval Academy in 1980, and served in the United States Navy in active duty until 1991, and as a reservist until 1996 when he retired at the rank of Lieutenant Commander. Mr. Williams’ awards include two Meritorious Service Medals, two Navy Commendation Medals, the National Defense Service Medal, the Navy Achievement Medal, two Navy Expeditionary Medals, the Armed Forces Expeditionary Medal and two Humanitarian Service Medals.

 

David Deming

With decades of senior-level investment banking experience, David serves as Partner and Chief Operating Officer of ID Fund LLC, an investor-directed firm for accredited investors. Mr. Deming formerly served as a director of Sorrento Therapeutics Inc. (NASDAQ: SRNE), a clinical stage and commercial-stage biopharmaceutical company that develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases, and has served on the board of numerous other public and private biotechnology companies, in addition to serving on the Board of Trustees of Hobart and William Smith Colleges for over a decade. Mr. Deming started his career at J.P. Morgan in 1976 and was a Managing Director in charge of the Global Healthcare Investment Banking Group from 1991 to 2003. Mr. Deming received a B.A. in Economics from Hobart College in 1975. 

 

Joseph J. Watson

With decades of executive-level experience as a leader and visionary in the pet industry, Joseph Watson is President and Chief Executive Officer of Petland, Inc., a global pet products retailer with stores in eight countries. Mr. Watson began at Petland as Vice President of Operations in November 2005 and then served as Chief Operating Officer prior to becoming CEO. Since July 2015, Mr. Watson has been a member of the Board of Trustees of Shawnee State University and serves as the Chairman of the Board of Trustees of Adena Health System, a medical services provider with four hospitals and six regional clinics in Ohio. Mr. Watson served in the United States Army from 1985 to 1987 and is also a National Guard veteran. Mr. Watson received a B.S. in Communications System Management from Ohio University in 1992, and received a Master’s in Business Administration from Ohio University in 1999.

 

Dr. Nicola Finley

As a board certified internal medicine physician with decades of experience as a practicing physician, Dr. Nicola R. Finley currently serves as Adjunct Faculty in the Health Promotion Sciences Division at the Mel and Enid Zuckerman College of Public Health at the University of Arizona, where she lectures to undergraduate, graduate and medical students, and presents to staff and faculty on the topic of personal wellness. Dr. Finley also serves as an Advisory Board Member of the Global Wellness Summit, an organization that gathers leaders and visionaries in the wellness industry, and serves as an Advisory Council Member at Luma Wealth, a wealth management firm that focuses on advising women and their families. Dr. Finley also serves as a Community Advisory Board Member of Arizona Public Media, a Southern Arizona-based non-profit public media service providing television and radio content including NPR and PBS to the area. Dr. Finley has had her research published in the American Journal of Lifestyle Medicine and Current Sexual Health Reports. Dr. Finley authored Function: A multidimensional view for the International Council on Active Aging®, and wrote the chapter on “Women’s Sleep” in Integrative Sleep Medicine published by Weil Integrative Medicine Library. Dr. Finley received a B.A. in Educational Studies from Brown University in 1994, and received a M.D. from the George Washington University School of Medicine in 1998. 

 

 

Christina Jefferson

Christina Jefferson has spent her career as a leader in the diversity, equity, and inclusion field and currently serves as the Director of Diversity, Equity, and Inclusion for the San Francisco 49ers. Jefferson spent six years of her career with Sephora, leading their diversity and inclusion efforts company wide. During her time at Sephora, Jefferson rose through the ranks working on social impact and diversity and inclusion programs to foster inclusivity across stores, corporate offices, and distribution centers.

 

Sources

  1. https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/feeling-good-the-future-of-the-1-5-trillion-wellness-market
  2. https://www.marketwatch.com/story/a-surge-in-blank-check-companies-this-year-could-drive-300-billion-in-m-a-in-202122-forecasts-goldman-11607963956

DISCLAIMER

Who are we and what do we do? We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (the “Information”) about publicly traded companies (the “Profiled Issuers”). How is the Information published? We publish the Information on our Website, in newsletters, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer or third party paying us. Our publication of the Information is known as a “Campaign”. Will everyone receive the Information at the same time? No. The Information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. How is a potential investor impacted if he receives the Information later than other investors? Typically, the trading volume and price of a Profiled Issuer’s securities increases after the Information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer increased trading losses if he purchases the securities of a Profiled Issuer. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase during the Campaign. What will happen when the Campaign ends? Most, if not all, of the Profiled Issuers are penny stocks that are illiquid and whose securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profiled Issuer will likely increase significantly. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment. Why do we publish only favorable Information? We only publish favorable information because we are compensated to publish only favorable information. Why don’t we publish negative Information? We don’t publish negative information because we are not paid to publish negative information. We are paid to publish only favorable information. Is the Information complete, accurate, truthful or reliable? No. The Information is a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful or reliable. What we do not do? We do not publish negative information about the Profiled Issuers. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities. Where does the Information come from? The Information is provided to us by the Profiled Issuers and/or the person who hires us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, the Securities and Exchange Commission’s Edgar database or other available public sources. If we say we make “stock picks,” are those picks our own? No, they are not. We are compensated to advertise the securities we are told to advertise. What will happen if an investor relies on the Information? If an investor relies on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision. Who pays us to publish the Information? The source of our compensation varies depending upon the particular circumstances of the Campaign. We are compensated by the Profiled Issuers, third party shareholders and other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities. The nature and amount of compensation we receive for publishing the Information about each Profiled Issuer and our ownership of each Profiled Issuer is set forth below under the heading captioned, “What we are compensated”. What warranties do we make about the Information? None. We make no warranty or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation. What we are not. We are not and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following:
  • An independent adviser or consultant;
  • A fortune teller;
  • An investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal or state level;
  • A broker-dealer or an individual acting in the capacity of a registered representative or broker;
  • A stock picker;
  • A securities trading expert;
  • A securities researcher or analyst;
  • A financial planner or one who engages in financial planning;
  • A provider of stock recommendations;
  • A provider of advice about buy, sell or hold recommendations as to specific securities; or
  • An agent offering or securities for sale or soliciting their purchase.
Are risks in this disclaimer the only risks investors should be aware of? No. There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer. What conflicts of interest do we have in publishing the Information? We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase. Our publication of the Information involves actual and material conflicts of interest including but not limited to the following:
  • We receive monetary and/or securities compensation in exchange for publishing the (favorable) Information about the Profiled Issuers;
  • We do not publish any negative information whatsoever about the Profiled Issuers;
  • We may own a Profiled Issuer’s securities that we acquired from the Profiled Issuer, third parties or from our own open market purchases before, during or after the Campaign and we may sell these securities during the Campaign while publishing the (favorable) information that instructs investors to purchase. Our selling of a Profiled Issuer’s securities will likely cause investors to suffer losses;
  • A short time after we acquire a Profiled Issuer’s securities, we may publish the (favorable) Information about the Profiled Issuer advising others, including you, to purchase; and while doing so, we may sell the Profiled Issuer’s securities we acquired during our public dissemination of the Information causing us to profit while you suffer a loss;
  • Parties holding a Profiled Issuer’s securities, including those who engage our services and/or compensate us, will sell their shares of the Profiled Issuer while we are publishing the (favorable) Information.
Who is responsible if an investor relies on the Information? The investor. We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions or errors in the Information, and we are not responsible for actions taken by any person who relies upon the Information. What do we urge potential investors to do? We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, OTC Markets, NASDAQ, NYSE, www.sec.gov or other available public sources. Why is this Disclaimer being provided? We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose our compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell our own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns. What are other risks that investors should be aware of? Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.
  • We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.
  • If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.
  • The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.
  • The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.
  • You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.
  • We or other stock promoters may receive free trading shares as compensation or we may acquire such shares in open market transactions before and during the Campaigns, and we may sell the shares we acquire at any time, even during the Campaigns while publishing the Favorable Information. When we sell the shares of the Profiled Issuers that we hold, the price at which investors can sell their shares will dramatically decrease and will likely cause investors to suffer trading losses.
  • We may sell securities of the Profiled Issuers for less than target prices set forth in the Information, and we may profit by selling our securities during the Campaigns while investors encounter losses.
  • When we acquire, purchase or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit us to make substantial profits while investors who purchase during the Campaign experience significant losses.
  • The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.
  • If we are compensated in improperly free trading securities of the Profiled Issuers, either directly or indirectly from persons who claim to be non-affiliates of such Profiled Issuer, we and the Profiled Issuer or third party could be subject to SEC Enforcement Action, including allegations of an illegal distribution in violation of Section 5(a) and 5(c) of the Securities Act.
  • We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and fail to disclose their compensation to you.
If a Profiled Issuer is an SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at www.otcmarkets.com, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions. If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies. The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.govwww.sec.gov, www.otcmarkets.com or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the OTCMarkets.com; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.org. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at otcmarkets.com. What we were paid to advertise the Profiled Issuers. The details of our compensation and the period of the Campaign is set forth below.
  • Name of Issuer & Ticker Symbol - Better For You Wellness, Inc. (BFYW)
  • Amount & Form of Compensation - $360,000 in Restricted Common Stock
  • Who Paid for the Campaign & Position with Company if any - Better For You Wellness, Inc. (BFYW)
  • Period of Campaign - 10/15/2021 - 10/14/2022
What securities of the Profiled Issuers do we hold? The positions we hold of the Profiled Issuer are set forth below. We plan to sell these securities during the Campaign.
  • Name of Issuer & Ticker Symbol - Better For You Wellness, Inc. (BFYW)
  • Number of Shares We or our Affiliates Hold - 2,465,753
  • Price We Paid Per Share - $0
  • Date Issued - 09/17/2021

Related Post

Register to Download Presentation

Go to website

Join the club

Subscribe to this newsletter

This email is already subscribed.

Go to top